Pervasive inflammatory activation in patients with deficiency in very‐long‐chain acyl‐coA dehydrogenase (VLCADD)

OBJECTIVES: Very‐long‐chain acyl‐CoA dehydrogenase deficiency (VLCADD) is a disorder of fatty acid oxidation. Symptoms are managed by dietary supplementation with medium‐chain fatty acids that bypass the metabolic block. However, patients remain vulnerable to hospitalisations because of rhabdomyolys...

Descripción completa

Detalles Bibliográficos
Autores principales: Vallejo, Abbe N, Mroczkowski, Henry J, Michel, Joshua J, Woolford, Michael, Blair, Harry C, Griffin, Patricia, McCracken, Elizabeth, Mihalik, Stephanie J, Reyes‐Mugica, Miguel, Vockley, Jerry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236555/
https://www.ncbi.nlm.nih.gov/pubmed/34194748
http://dx.doi.org/10.1002/cti2.1304

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236555/
https://www.ncbi.nlm.nih.gov/pubmed/34194748
http://dx.doi.org/10.1002/cti2.1304

Ejemplares similares